Treatment outcomes of PCR-positive acute retinal necrosis
- PMID: 37365446
- DOI: 10.1007/s11845-023-03426-2
Treatment outcomes of PCR-positive acute retinal necrosis
Abstract
Background: Acute retinal necrosis (ARN) is a progressive necrotizing retinitis caused by viral infection. Optimal management strategies have not been established for this detrimental disease. Previous literature published suggests that Varicella-zoster virus (VZV) and Herpes simplex virus-1 (HSV1) are the most common promoters of acute retinal necrosis (ARN).
Aims: The purpose of our study was to investigate the viral distribution, demographic, and treatment outcomes of ARN.
Methods: A retrospective chart review evaluated data from PCR-positive ARN patients diagnosed between 2009 and 2018.
Results: Analysis of fourteen eyes from 12 patients found CMV and VZV as the commonest causes of ARN. Patients on 1 g of valacyclovir three times a day (V1T) had worse vision between first and final visits (mean difference of 1.25 ± 0.65, n = 2) compared with patients treated with 2 g of valacyclovir three times a day (V2T), or 900 mg twice a day of valganciclovir (V9B) (mean difference of - 0.067 ± 0.13, n = 6, and 0.067 ± 0.067, n = 6, respectively). Both V1T patients developed retinal detachments (RD). Both CMV patients treated with intravitreal triamcinolone developed ARN, elevated IOP, and one developed multiple RD.
Conclusions: Our review found increased incidence of CMV-positive ARN. Patients with zone 1 disease had worse initial visual acuity. Moreover, patients had more favorable outcomes with V2T and V9B compared to V1T. CMV-positive patients clinically worsened after intravitreal steroid injections, further underscoring the value of a PCR diagnosis to tailor the patients' treatment plan accordingly.
Keywords: Infectious disease; Panuveitis; Retinitis; Uveitis; Vitritis.
© 2023. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.
References
-
- Holland GN (1994) Standard diagnostic criteria for the acute retinal necrosis syndrome. Executive Committee of the American Uveitis Society. Am J Ophthalmol 117(5):663–667. http://www.ncbi.nlm.nih.gov/pubmed/8172275 . Accessed 19 Dec 2018
-
- Culbertson WW, Blumenkranz MS, Haines H et al (1982) The acute retinal necrosis syndrome. Part 2: histopathology and etiology. Ophthalmology 89(12):1317–1325. http://www.ncbi.nlm.nih.gov/pubmed/6298683 . Accessed 19 Dec 2018
-
- Muthiah MN, Michaelides M, Child CS, Mitchell SM (2007) Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK. Br J Ophthalmol 91(11):1452–1455. https://doi.org/10.1136/bjo.2007.114884 - DOI - PubMed - PMC
-
- Butler NJ, Moradi A, Salek SS et al (2017) Acute retinal necrosis: presenting characteristics and clinical outcomes in a cohort of polymerase chain reaction-positive patients. Am J Ophthalmol 179:179–189. https://doi.org/10.1016/j.ajo.2017.05.006 - DOI - PubMed
-
- Shantha JG, Weissman HM, Debiec MR et al (2015) Advances in the management of acute retinal necrosis. Int Ophthalmol Clin 55(3):1–13. https://doi.org/10.1097/IIO.0000000000000077 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
